Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of miRNAs contributing to neuroblastoma chemoresistance

1 Jan 2015

Abstract excerpt

BACKGROUND: The emergence of the role of microRNAs (miRNAs) in exacerbating drug resistance of tumours is recently being highlighted as a crucial research field for future clinical management of drug resistant tumours. The purpose of this study was to identify dys-regulations in expression of individual and/or networks of miRNAs that may have direct effect on neuroblastoma (NB) drug resistance. METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to MicroRNA in disease regulation
Share to Microtubule and mitosis dynamics
Share to Neuroblastoma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25973145
DOI: 10.1016/j.csbj.2015.04.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of miRNAs contributing to neuroblastoma chemoresistancePMID 25973145Read ↗

MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolutionSemantic proximity Read ↗

The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitroSemantic proximity Read ↗

MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genesSemantic proximity Read ↗

LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3pSemantic proximity Read ↗

Mesenchymal change and drug resistance in neuroblastoma.Semantic proximity Read ↗

Non-Hodgkin’s B-cell lymphoma: Advances in molecular strategies targeting drug resistanceSemantic proximity Read ↗

Differential Patterns of MicroRNA Expression in Neuroblastoma Are Correlated with Prognosis, Differentiation, and ApoptosisSemantic proximity Read ↗

Role of microRNAs in chemoresistance.Semantic proximity Read ↗

Therapy resistance in neuroblastoma: Mechanisms and reversal strategiesSemantic proximity Read ↗

Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells.Semantic proximity Read ↗

MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel‐induced multidrug resistanceSemantic proximity Read ↗

Reverse molecular pharmacology identifies the non-canonical axis of IRAK as a chemoresistance factor in neuroblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.